Tolerability of MDMA in Schizophrenia

Phase: PHASE1, PHASE2 | Sponsor: Anya Bershad, MD, PhD | Compound: MDMA

Status

recruiting

Institution

Anya Bershad, MD, PhD

Start date

2025-04-01

End date

2027-03-01

Registry ID

NCT05770375

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.